Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

[Translated article] Sudden-Onset Generalized Millimetric Papulosquamous Lesions in a Patient With Fever.

Actas dermo-sifiliograficas·2022

Same author

Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement.

Actas dermo-sifiliograficas·2020

Same author

Body dysmorphic disorder in patients with acne: a multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Same author

Skin Tumors Arising on Chronic Lymphedema.

Actas dermo-sifiliograficas·2017

Same author

Guidelines on the Use of Methotrexate in Psoriasis.

Actas dermo-sifiliograficas·2017

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

[Corticosteroids and osteoporosis].

M García-Bustínduy¹, M A Gantes

¹Servicio de Dermatología. Hospital Universitario de Canarias. La Laguna. Tenerife. España. mgarciab@ull.es

Actas Dermo-Sifiliograficas

|October 9, 2007

Summary

Corticosteroids, commonly used medications, significantly increase the risk of secondary osteoporosis and fractures with prolonged use or high doses. Awareness and preventative measures are crucial for patient bone health.

Area of Science:

Endocrinology
Pharmacology
Bone Metabolism

Context:

Corticosteroids are widely prescribed for various inflammatory and autoimmune conditions.
Drug-induced secondary osteoporosis is a significant clinical concern.
Long-term corticosteroid use is a leading cause of iatrogenic bone loss.

Purpose:

To highlight the link between corticosteroid therapy and secondary osteoporosis.
To emphasize the dose and duration thresholds that elevate risk.
To underscore the importance of risk mitigation strategies for patients.

Summary:

Corticosteroids are the primary pharmacological cause of secondary osteoporosis.
Daily doses exceeding 5 mg and treatment durations over 3 months elevate the risk of osteoporosis and fragility fractures.

Related Experiment Videos

Last Updated: Jul 11, 2026

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

Proactive management is essential to prevent bone density loss in patients on corticosteroids.

Impact:

Informing healthcare providers about the bone health risks associated with corticosteroid treatment.
Promoting early identification and intervention for patients at risk of secondary osteoporosis.
Reducing the incidence of osteoporotic fractures in patients undergoing corticosteroid therapy.